
    
      This is a multi-center observational study. Treatment and follow-up visits will be performed
      as per standard of care. The purpose of this study is to demonstrate that use of the
      FREDTM/FREDTM Jr Embolic device in intracranial aneurysm treatment is safe and effective when
      assessed at 6, 12 months and yearly up to 5 years post procedure.

      150 patients will be enrolled over an 15-month recruitment period. All patients will be
      followed for 5 years.
    
  